
Opinion|Videos|February 6, 2025
Factoring in Safety Considerations With IV Iron Products
Panelists discuss how black box warnings on IV iron products, particularly regarding hypersensitivity reactions, influence their risk assessment, patient selection, monitoring protocols, and facility requirements for administration, while emphasizing that modern formulations have significantly improved safety profiles compared with older products.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How does the presence of a black box warning on certain IV iron products influence your clinical decision-making process?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
5





